Skip to main content
Premium Trial:

Request an Annual Quote

Cuts at Pfizer in Canada

Pfizer is laying off 300 people from its Canadian workforce, reports The Globe and Mail. That represents about 11 percent of its workers in that country, the paper adds.

"The move comes more than a year after the drugmaker disclosed plans to cut another $1 billion or so in expenses, with a first phase that will amount to $500 million in cutbacks that were to take place last year," writes Ed Silverman at Pharmalot. "The move came in response to the loss of patent protection for the Lipitor cholesterol pill, a $10.7 billion seller, and other big-selling meds."

Most of the cuts will be to Pfizer's sales and marketing force. “We have been forced to adjust our sales force to reflect the changes the pharmaceutical industry is undergoing, namely the loss of patent protection on bestselling drugs,” says Rhonda O'Gallagher, the executive director of corporate communications at Pfizer Canada, in The Globe and Mail.

For Montreal, where Pfizer's Canadian headquarters are located, this is only the latest of changes to the pharmaceutical industry, The Globe and Mail notes. Earlier in the year, Boehringer Ingelheim announced that it would be closing its facility just north of Montreal, and other pharma companies have also had layoffs and closures in the past few years.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.